Animal Stem Cell Therapy Market - By Therapy Type: Autologous Stem Cells, Allogeneic Stem Cells, Induced Pluripotent Stem Cells (iPSC); By Application: Orthopedics, Oncology, Dermatology, By Animal Type: Companion Animals, Livestock, Exotic Animals; By Region: North America, Europe, Asia-Pacific Latin America and Middle East and Africa
The global Animal Stem Cell Therapy Market is projected to grow from 920 Mn in 2024 to 3.8 B nby 2031, at a 26% CAGR, driven by the adoption of regenerative medicine in equine and canine osteoarthritis treatment.
Market Segmentation
1.1 By Therapy Type
1.2 By Application
1.3 By Animal Type
1.4 By Geography
2. Key Growth Drivers
2.1 Clinical Efficacy
|
Condition |
Stem Cell Success Rate |
Traditional Treatment |
|
Canine Osteoarthritis |
78% mobility improvement |
45% (with NSAIDs) |
|
Equine Tendonitis |
6-month recovery |
12-month recovery |
2.2 Regulatory Support
2.3 Economic Factors
3. Competitive Landscape
|
Company |
Breakthrough |
Market Impact |
|
VetStem |
50K+ canine treatments |
$180M revenue (2025) |
|
Aratana |
Off-the-shelf MSCs |
40% cost reduction |
|
Magellan |
Equine amniotic stem cells |
90% tendon healing rate |
4. Future Outlook (2025–2031)
Need help?
Chat with our team in a minute.